147 related articles for article (PubMed ID: 22002347)
1. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses.
Blyth E; Clancy L; Simms R; Gaundar S; O'Connell P; Micklethwaite K; Gottlieb DJ
Transplantation; 2011 Nov; 92(10):1077-84. PubMed ID: 22002347
[TBL] [Abstract][Full Text] [Related]
2. Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity.
Trydzenskaya H; Sattler A; Müller K; Schachtner T; Dang-Heine C; Friedrich P; Nickel P; Hoerstrup J; Schindler R; Thiel A; Melzig MF; Reinke P; Babel N
Transplantation; 2011 Dec; 92(11):1269-77. PubMed ID: 22124284
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults.
Zhou W; Sharma M; Martinez J; Srivastava T; Diamond DJ; Knowles W; Lacey SF
Viral Immunol; 2007 Sep; 20(3):379-88. PubMed ID: 17931108
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation.
Fan Y; Bai H; Qian Y; Sun Z; Shi B
Surg Infect (Larchmt); 2019 Apr; 20(3):236-243. PubMed ID: 30707648
[TBL] [Abstract][Full Text] [Related]
5. Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients.
Randhawa PS; Popescu I; Macedo C; Zeevi A; Shapiro R; Vats AN; Metes D
Hum Immunol; 2006; 67(4-5):298-302. PubMed ID: 16720209
[TBL] [Abstract][Full Text] [Related]
6. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients.
Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E
Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870
[TBL] [Abstract][Full Text] [Related]
7. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
[TBL] [Abstract][Full Text] [Related]
8. Unique BK virus non-coding control region (NCCR) variants in hematopoietic stem cell transplant recipients with and without hemorrhagic cystitis.
Carr MJ; McCormack GP; Mutton KJ; Crowley B
J Med Virol; 2006 Apr; 78(4):485-93. PubMed ID: 16482558
[TBL] [Abstract][Full Text] [Related]
9. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
[TBL] [Abstract][Full Text] [Related]
10. BK-VP3 as a new target of cellular immunity in BK virus infection.
Mueller K; Schachtner T; Sattler A; Meier S; Friedrich P; Trydzenskaya H; Hinrichs C; Trappe R; Thiel A; Reinke P; Babel N
Transplantation; 2011 Jan; 91(1):100-7. PubMed ID: 21452414
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.
Krymskaya L; Sharma MC; Martinez J; Haq W; Huang EC; Limaye AP; Diamond DJ; Lacey SF
J Virol; 2005 Sep; 79(17):11170-8. PubMed ID: 16103168
[TBL] [Abstract][Full Text] [Related]
12. Polyomavirus-associated nephropathy: update on BK virus-specific immunity.
Comoli P; Binggeli S; Ginevri F; Hirsch HH
Transpl Infect Dis; 2006 Jun; 8(2):86-94. PubMed ID: 16734631
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients.
Comoli P; Basso S; Azzi A; Moretta A; De Santis R; Del Galdo F; De Palma R; Valente U; Nocera A; Perfumo F; Locatelli F; Maccario R; Ginevri F
J Am Soc Nephrol; 2003 Dec; 14(12):3197-204. PubMed ID: 14638918
[TBL] [Abstract][Full Text] [Related]
14. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus.
Li J; Melenhorst J; Hensel N; Rezvani K; Sconocchia G; Kilical Y; Hou J; Curfman B; Major E; Barrett AJ
J Gen Virol; 2006 Oct; 87(Pt 10):2951-2960. PubMed ID: 16963754
[TBL] [Abstract][Full Text] [Related]
15. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
[TBL] [Abstract][Full Text] [Related]
16. Virus specific antigens in BK virus-transformed cells detected by cell-mediated immune reactions.
Karjalainen HE; Laaksonen AM; Mäntyjärvi RA
Med Biol; 1983 Feb; 61(1):73-8. PubMed ID: 6302408
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
[TBL] [Abstract][Full Text] [Related]
18. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance.
Mani J; Wang L; Hückelhoven AG; Schmitt A; Gedvilaite A; Jin N; Kleist C; Ho AD; Schmitt M
Oncotarget; 2017 Jan; 8(2):2485-2500. PubMed ID: 27705933
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals.
Sharma MC; Zhou W; Martinez J; Krymskaya L; Srivastava T; Haq W; Diamond DJ; Lacey SF
Virology; 2006 Jun; 350(1):128-36. PubMed ID: 16600320
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
